ArticleCancer immunology research2022

IDO Vaccine Ablates Immune-Suppressive Myeloid Populations and Enhances Antitumor Effects Independent of Tumor Cell IDO Status.

Rahul Nandre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.